Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients.
Maraviroc intensification for suboptimal CD4⁺ T cell response in a perinatally HIV-infected adolescent.
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
Clinical management of HIV-1 resistance.
IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.